about
Protoporphyrin IX fluorescence photobleaching and the response of rat Barrett's esophagus following 5-aminolevulinic acid photodynamic therapy.Development of an Online, Evidence-Based Patient Information Portal for Congenital Heart Disease: A Pilot StudyCardiologist and cardiac surgeon view on decision-making in prosthetic aortic valve selection: does profession matter?CT and myasthenia gravis: correlation between mediastinal imaging and histopathological findings.Directing valvular interstitial cell myofibroblast-like differentiation in a hybrid hydrogel platform.Prosthetic aortic valve selection: current patient experience, preferences and knowledgeMortality after cardiac surgery in patients with liver cirrhosis classified by the Child-Pugh score.Aortic root dimension changes during systole and diastole: evaluation with ECG-gated multidetector row computed tomography.Valvular interstitial cells suppress calcification of valvular endothelial cells.Intraoperative High-Dose Dexamethasone and Severe AKI after Cardiac SurgeryIschemia of the lung causes extensive long-term pulmonary injury: an experimental studySimulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation.Sequential use of human-derived medium supplements favours cardiovascular tissue engineering.Conceptual model for early health technology assessment of current and novel heart valve interventions.Environmental regulation of valvulogenesis: implications for tissue engineering.Inflammation in new-onset atrial fibrillation after cardiac surgery: a systematic review.Does the Use of a Decision Aid Improve Decision Making in Prosthetic Heart Valve Selection? A Multicenter Randomized Trial.Fifteen years' experience with the use of artificial chords for valve reconstruction in children†.The flaws in the detail of an observational study on transcatheter aortic valve implantation versus surgical aortic valve replacement in intermediate-risks patients.In situ heart valve tissue engineering using a bioresorbable elastomeric implant - From material design to 12 months follow-up in sheep.Identification of the Asymptomatic Patient With Severe Mitral Regurgitation: Discrepancy Between Research and Clinical Practice.Valve-sparing root replacement in children.Early mitral valve repair versus watchful waiting in patients with severe asymptomatic organic mitral regurgitation; rationale and design of the Dutch AMR trial, a multicenter, randomised trial.ENerGetIcs in hypertrophic cardiomyopathy: traNslation between MRI, PET and cardiac myofilament function (ENGINE study).The effects of intraoperative dexamethasone on left atrial function and postoperative atrial fibrillation in cardiac surgical patients.Development of Non-Cell Adhesive Vascular Grafts Using Supramolecular Building Blocks.Automated 3D analysis of pre-procedural MDCT to predict annulus plane angulation and C-arm positioning: benefit on procedural outcome in patients referred for TAVR.A prospective "oversizing" strategy of the Edwards SAPIEN bioprosthesis: results and impact on aortic regurgitation.Chronic alcoholic donors in heart transplantation: A mortality meta-analysis.Left bundle-branch block induced by transcatheter aortic valve implantation increases risk of death.Optimisation of transcatheter aortic balloon-expandable valve deployment: the two-step inflation technique.Measuring what matters to the patient: health related quality of life after aortic valve and thoracic aortic surgery.An easy-to-use scoring index to determine severity of mitral regurgitation by 2D echocardiography in clinical practice.Embrella embolic deflection device for cerebral protection during transcatheter aortic valve replacement.Aortic valve stenosis and aortic diameters determine the extent of increased wall shear stress in bicuspid aortic valve disease.Delirium detection based on monitoring of blinks and eye movements.Pathology of aortic valve remodeling after continuous-flow left ventricular assist device support.Long-term results after modified Gallie technique for incisional hernia repair: results in 19 patients.Early in-situ cellularization of a supramolecular vascular graft is modified by synthetic stromal cell-derived factor-1α derived peptides.In Situ Tissue Engineering of Functional Small-Diameter Blood Vessels by Host Circulating Cells Only.
P50
Q33252347-D383AE87-5AC6-4336-9A5B-513AB8D3C485Q33619577-9C00E4C2-C169-4CBD-BDDE-861AE21DF9E6Q33906071-65590CA6-A7CD-49E0-B426-FEA946A254FAQ34658568-B5FCD711-5301-487A-A671-A2F77AF155A4Q34772618-2ECF4300-D3D9-4C91-8282-3EBDF2851DDBQ35399757-93D20E04-DA1E-4B0C-9AB7-5BD734751949Q35547461-EF678EDB-3885-44AF-A239-8219A53273E1Q35592914-F8B71302-60BA-4E85-84E0-2DF819D6DE8EQ35988417-3435BDB1-E0DB-44F0-BA87-6321A26D9170Q36314938-B31A0F88-EBAE-42D2-8432-124775991F33Q36585167-BDAF04F7-BA09-4F4A-8506-74A83F36016AQ37000195-178BACCE-A85C-4B79-BB68-C5D7D486BC8DQ37294609-CDCC5016-B4BE-4995-B2D9-437C722E4340Q37355880-C0301EE6-E631-4FDE-8106-571871645C20Q37773530-8AF78766-A373-4E1C-A44D-9E4034E76057Q38175522-F365EA4E-63DB-4A33-831C-5E73387894B2Q38380429-12851C0B-489B-4F99-A1C4-792A8BCEDD7EQ38768976-76E1CFD0-6533-4D5F-A74B-15FE2E120525Q38771029-97B9BA9D-A035-4333-B35C-000EB29AF319Q38932847-8788AFB3-E074-4C79-B296-B395EDC46B83Q38933944-DD66C8E6-641F-459F-96DF-794D7FF6A168Q39582302-1C74FACA-F09E-4AD1-82BE-8A1F0743EBC9Q41542177-42C5EDCA-AF8A-40D8-AA4B-E4777FCA1335Q41815143-590FD168-872B-4AF2-837A-C02D187E2362Q42108726-92438676-3131-41F8-8E2B-18D3685A1428Q42817606-488BA360-927B-4CD7-BC31-56ED7CF9C626Q44562886-62F8B953-5A3B-4997-97CA-3DD39B6A94E3Q44604255-663F53BD-4896-42A0-82D7-A28587C2E630Q44632761-6EF1DF7A-82AE-4C18-A5CD-9DCC4D553ECBQ46057124-0A03E892-47A8-4F56-9543-B3CF8C8B6FD7Q46116166-0059FFEC-D722-4D7E-8129-8DC55B61D5F6Q47950040-FE9D5AFF-1741-4FC5-96D3-EDEF8F74E5D6Q48192546-480CFB71-86C3-491F-B71C-482BB88E5A5EQ48431830-9837A817-4691-4F36-86E6-8CE44F104131Q49924406-0BFD836A-35EC-42C4-8FF3-0044122E3FD0Q50661728-1DD1D06A-45D4-41BD-B5C5-B07FC1CEB343Q51083742-3D06EC9A-2675-48E8-88C6-7691AE4382B4Q51636683-2F3ECFBB-E85B-49E7-80B6-16FFFAB22661Q51662689-FD9F9AA1-53DC-4619-A5F2-9D64B29B0CFFQ51838392-7D5ACC39-B8E1-42EC-B4FA-1497BC4EF3A4
P50
description
investigador
@es
researcher
@en
name
Jolanda Kluin
@en
type
label
Jolanda Kluin
@en
prefLabel
Jolanda Kluin
@en
P31
P496
0000-0002-5942-4727